
N4 Pharma Plc
(LSE) N4P
N4 Pharma Plc Financials at a Glance
Market Cap
N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
£12.93K
Net Income (TTM)
-£2.18M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Estimated Earnings Date
Mar 19, 2026
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Estimated Earnings Date
Mar 19, 2026
N4P News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout N4 Pharma Plc
Industry
Pharmaceuticals
Sector
Health CareCEO
Nigel James Theobald
Website
www.n4pharma.comHeadquarters
London, EC3V 0HR, GB
N4P Financials
Key Financial Metrics (TTM)
Gross Margin
0.00%
Operating Margin
-15199.56%
Net Income Margin
-16589.87%
Return on Equity
-84.97%
Return on Capital
-188.53%
Return on Assets
-103.13%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
N/A
Volume
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
£9.24K
Operating Income
-£2.41M
EBITDA
-£2.47M
Operating Cash Flow
-£2.04M
Capital Expenditure
-£3.00
Free Cash Flow
-£2.04M
Cash & ST Invst.
£1.73M
Total Debt
£0.00
N4 Pharma Plc Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
£3.69K
N/A
Gross Profit
£0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
N/A
N/A
Employees
5
N/A
Net Income
-£498.55K
+22.8%
EBITDA
-£470.22K
+27.2%
Quarterly Fundamentals
Total Cash
£1.73M
+33.9%
Total Debt
£0.00
N/A
Accounts Receivable
£118.11K
-43.6%
Inventory
£0.00
N/A
Long Term Debt
£0.00
N/A
Short Term Debt
£0.00
N/A
Return on Assets
-1.03%
N/A
Return on Invested Capital
-1.03%
N/A
Free Cash Flow
-£444.37K
+28.9%
Operating Cash Flow
-£444.37K
+28.9%